4.7 Review

Chromogranin A: a paradoxical player in angiogenesis and vascular biology

期刊

CELLULAR AND MOLECULAR LIFE SCIENCES
卷 72, 期 2, 页码 339-348

出版社

SPRINGER BASEL AG
DOI: 10.1007/s00018-014-1750-9

关键词

ELISA assays; Endothelial barrier; Angiogenic switch; Cardiovascular regulation; Cancer; Proteolytic processing

资金

  1. Associazione Italiana per la Ricerca sul Cancro of Italy [AIRC 14338, 9965]

向作者/读者索取更多资源

Half a century after the discovery of chromogranin A as a secreted product of the catecholamine storage granules in the bovine adrenal medulla, the physiological role for the circulating pool of this protein has been recently coined, namely as an important player in vascular homeostasis. While the circulating chromogranin A since 1984 has proved to be a significant and useful marker of a wide range of pathophysiological and pathological conditions involving the diffuse neuroendocrine system, this protein has now been assigned a physiological raison d'etre as a regulator in vascular homeostasis. Moreover, chromogranin A processing in response to tissue damage and blood coagulation provides the first indication of a difference in time frame of the regulation of angiogenesis evoked by the intact chromogranin A and its two major peptide products, vasostatin-1 and catestatin. The impact of these discoveries on vascular homeostasis, angiogenesis, cancer, tissue repair and cardio-regulation will be discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors

Teresa Manzo, Tabea Sturmheit, Veronica Basso, Elisabetta Petrozziello, Rodrigo Hess Michelini, Michela Riba, Massimo Freschi, Angela R. Elia, Matteo Grioni, Flavio Curnis, Maria Pia Protti, Ton N. Schumacher, Reno Debets, Melody A. Swartz, Angelo Corti, Matteo Bellone, Anna Mondino

CANCER RESEARCH (2017)

Article Endocrinology & Metabolism

Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice

Kechun Tang, Teresa Pasqua, Angshuman Biswas, Sumana Mahata, Jennifer Tang, Alisa Tang, Gautam K. Bandyopadhyay, Amiya P. Sinha-Hikim, Nai-Wen Chi, Nicholas J. G. Webster, Angelo Corti, Sushil K. Mahata

JOURNAL OF ENDOCRINOLOGY (2017)

Article Oncology

Regulation of tumor growth by circulating full-length chromogranin A

Flavio Curnis, Alice Dallatomasina, Mimma Bianco, Anna Gasparri, Angelina Sacchi, Barbara Colombo, Martina Fiocchi, Laura Perani, Massimo Venturini, Carlo Tacchetti, Suvajit Sen, Ricardo Borges, Eleonora Dondossola, Antonio Esposito, Sushil K. Mahata, Angelo Corti

ONCOTARGET (2016)

Article Cardiac & Cardiovascular Systems

Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study

Tiziana Bachetti, Alberto Ferrari Bardile, Teresa Lucia Aloi, Barbara Colombo, Emma Assi, Giuseppina Savino, Andrea Vercelli, Roberto Colombo, Angelo Corti

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Review Physiology

Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers

Angelo Corti, Fabrizio Marcucci, Tiziana Bachetti

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)

Review Neurosciences

Granin-derived peptides

Josef Troger, Markus Theurl, Rudolf Kirchmair, Teresa Pasqua, Bruno Tota, Tommaso Angelone, Maria C. Cerra, Yvonne Nowosielski, Raphaela Matzler, Jasmin Troger, Jaur R. Gayen, Vance Trudeau, Angelo Corti, Karen B. Helle

PROGRESS IN NEUROBIOLOGY (2017)

Article Oncology

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy

Angela Rita Elia, Matteo Grioni, Veronica Basso, Flavio Curnis, Massimo Freschi, Angelo Corti, Anna Mondino, Matteo Bellone

CLINICAL CANCER RESEARCH (2018)

Article Endocrinology & Metabolism

Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity

Wei Ying, Sumana Mahata, Gautam K. Bandyopadhyay, Zhenqi Zhou, Joshua Wollam, Jessica Vu, Rafael Mayoral, Nai-Wen Chi, Nicholas J. G. Webster, Angelo Corti, Sushil K. Mahata

DIABETES (2018)

Article Multidisciplinary Sciences

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms

Andrea Corsello, Luigi Di Filippo, Sara Massironi, Federica Sileo, Anna Dolcetta Capuzzo, Marco Gemma, Claudia Carlucci, Claudio Cusini, Barbara Colombo, Alice Dallatomasina, Giulia Maria Franchi, Angelo Corti, Marco Federico Manzoni

PLOS ONE (2018)

Review Oncology

Breaching the Blood-Brain Tumor Barrier for Tumor Therapy

Fabrizio Marcucci, Angelo Corti, Andres J. M. Ferreri

Summary: The blood-brain tumor barrier (BBTB) is a major obstacle for delivering anticancer drugs to central nervous system tumors. Recent advances in various conjugates and drug delivery technologies have shown promising results in breaching the BBTB and increasing drug delivery to brain tumors, without significant adverse events.

CANCERS (2021)

Review Pharmacology & Pharmacy

Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-α

Angelo Corti, Teresa Calimeri, Flavio Curnis, Andres J. M. Ferreri

Summary: The blood-brain tumor barrier is a major obstacle for the delivery of anticancer drugs to brain tumors. This review focuses on the development of a drug called NGR-TNF that can target and alter the blood-brain tumor barrier. Preclinical studies have shown that NGR-TNF is a promising strategy for delivering TNF to tumor vessels and breaking the biological barriers. Clinical studies have also demonstrated the efficacy of NGR-TNF in improving patient survival. In addition, the review discusses the challenges and potential solutions for the instability and molecular heterogeneity of NGR-TNF, as well as other peptide/antibody-TNF fusion products and nanoparticles for targeting the blood-brain tumor barrier.

PHARMACEUTICS (2022)

Review Pharmacology & Pharmacy

Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care

Francis Schneider, Raphael Clere-Jehl, Francesco Scavello, Thierry Lavigne, Angelo Corti, Tommaso Angelone, Youssef Haikel, Philippe Lavalle

Summary: CGA may serve as a biomarker in critically ill patients, associated with short-term death, systemic inflammation, and multiple organ failure; Vasostatin-I, when associated with age and lactate, could be an early prognostic indicator; Catestatin impacts immunity-related proteins and helps fight infections.

PHARMACEUTICS (2022)

Review Biochemistry & Molecular Biology

Tumor cell-associated immune checkpoint molecules - Drivers of malignancy and stemness

Fabrizio Marcucci, Cristiano Rumio, Angelo Corti

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)

Article Chemistry, Multidisciplinary

Glycine N-Methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate Formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing

Angelo Corti, Anna Maria Gasparri, Michela Ghitti, Angelina Sacchi, Francesco Sudati, Martina Fiocchi, Valentina Buttiglione, Laura Perani, Alessandro Gori, Silvia Valtorta, Rosa Maria Moresco, Fabio Pastorino, Mirco Ponzoni, Giovanna Musco, Flavio Curnis

ADVANCED FUNCTIONAL MATERIALS (2017)

Article Cell Biology

Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion

Joshua Wollam, Sumana Mahata, Matthew Riopel, Angelina Hernandez-Carretero, Angshuman Biswas, Gautam K. Bandyopadhyay, Nai-Wen Chi, Lee E. Eiden, Nitish R. Mahapatra, Angelo Corti, Nicholas J. G. Webster, Sushil K. Mahata

CELL AND TISSUE RESEARCH (2017)

暂无数据